These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37266387)

  • 1. Local, systemic and immunologic safety comparison between xenogeneic equine umbilical cord mesenchymal stem cells, allogeneic canine adipose mesenchymal stem cells and placebo: a randomized controlled trial.
    Punzón E; García-Castillo M; Rico MA; Padilla L; Pradera A
    Front Vet Sci; 2023; 10():1098029. PubMed ID: 37266387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine umbilical cord mesenchymal stem cells demonstrate safety and efficacy in the treatment of canine osteoarthritis: a randomized placebo-controlled trial.
    Punzón E; Salgüero R; Totusaus X; Mesa-Sánchez C; Badiella L; García-Castillo M; Pradera A
    J Am Vet Med Assoc; 2022 Oct; 260(15):1947-1955. PubMed ID: 36198051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing.
    Beerts C; Broeckx SY; Depuydt E; Tack L; Van Hecke L; Chiers K; Van Brantegem L; Braun G; Hellmann K; de Bouvre N; Van Bruaene N; De Ryck T; Duchateau L; Van Ryssen B; Peremans K; Saunders JH; Verhoeven G; Pauwelyn G; Spaas JH
    Arthritis Res Ther; 2023 Oct; 25(1):190. PubMed ID: 37789403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.
    Van Hecke L; Magri C; Duchateau L; Beerts C; Geburek F; Suls M; Da Dalt L; Patruno M; Saunders J; Broeckx SY; Depuydt E; Spaas JH
    Vet Immunol Immunopathol; 2021 Sep; 239():110306. PubMed ID: 34365135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
    Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
    Vet Immunol Immunopathol; 2013 Nov; 156(1-2):99-106. PubMed ID: 24094688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunomodulatory effects of allogeneic canine adipose-derived mesenchymal stromal cells transplanted into the region of the lacrimal gland, the gland of the third eyelid and the knee joint.
    Park SA; Reilly CM; Wood JA; Chung DJ; Carrade DD; Deremer SL; Seraphin RL; Clark KC; Zwingenberger AL; Borjesson DL; Hayashi K; Russell P; Murphy CJ
    Cytotherapy; 2013 Dec; 15(12):1498-510. PubMed ID: 23992828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Injection of Equine Mesenchymal Stem Cells in Dogs with Articular Pain and Lameness: A Feasibility Study.
    Brondeel C; Weekers F; van Hecke L; Depuydt E; Pauwelyn G; Verhoeven G; de Bouvré N; De Roeck P; Vandekerckhove P; Vanacker P; Böhm-Geerdink D; Daems R; Duchateau L; Saunders J; Samoy Y; Spaas JH
    Stem Cells Dev; 2023 Jun; 32(11-12):292-300. PubMed ID: 36924281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.
    Matas J; Orrego M; Amenabar D; Infante C; Tapia-Limonchi R; Cadiz MI; Alcayaga-Miranda F; González PL; Muse E; Khoury M; Figueroa FE; Espinoza F
    Stem Cells Transl Med; 2019 Mar; 8(3):215-224. PubMed ID: 30592390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-articular administration of xenogeneic neonatal Mesenchymal Stromal Cells early after meniscal injury down-regulates metalloproteinase gene expression in synovium and prevents cartilage degradation in a rabbit model of osteoarthritis.
    Saulnier N; Viguier E; Perrier-Groult E; Chenu C; Pillet E; Roger T; Maddens S; Boulocher C
    Osteoarthritis Cartilage; 2015 Jan; 23(1):122-33. PubMed ID: 25219668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial.
    Lee WS; Kim HJ; Kim KI; Kim GB; Jin W
    Stem Cells Transl Med; 2019 Jun; 8(6):504-511. PubMed ID: 30835956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal/metatarsophalangeal joint in horses: A clinical pilot study.
    Magri C; Schramme M; Febre M; Cauvin E; Labadie F; Saulnier N; François I; Lechartier A; Aebischer D; Moncelet AS; Maddens S
    PLoS One; 2019; 14(8):e0221317. PubMed ID: 31465445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Safety and Efficacy of Single or Repeated Intra-Articular Injection of Allogeneic Neonatal Mesenchymal Stromal Cells for Managing Pain and Lameness in Moderate to Severe Canine Osteoarthritis Without Anti-inflammatory Pharmacological Support: Pilot Clinical Study.
    Cabon Q; Febre M; Gomez N; Cachon T; Pillard P; Carozzo C; Saulnier N; Robert C; Livet V; Rakic R; Plantier N; Saas P; Maddens S; Viguier E
    Front Vet Sci; 2019; 6():10. PubMed ID: 30805348
    [No Abstract]   [Full Text] [Related]  

  • 14. Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses.
    Bertoni L; Branly T; Jacquet S; Desancé M; Desquilbet L; Rivory P; Hartmann DJ; Denoix JM; Audigié F; Galéra P; Demoor M
    Stem Cells Int; 2019; 2019():9431894. PubMed ID: 31191689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Effects of Intra-Articular Allogenic Mesenchymal Stem Cell Secretome in an Equine Model of Joint Inflammation.
    Kearney CM; Khatab S; van Buul GM; Plomp SGM; Korthagen NM; Labberté MC; Goodrich LR; Kisiday JD; Van Weeren PR; van Osch GJVM; Brama PAJ
    Front Vet Sci; 2022; 9():907616. PubMed ID: 35812845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
    Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
    Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.
    Carrade DD; Owens SD; Galuppo LD; Vidal MA; Ferraro GL; Librach F; Buerchler S; Friedman MS; Walker NJ; Borjesson DL
    Cytotherapy; 2011 Apr; 13(4):419-30. PubMed ID: 21105841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions.
    Carrade DD; Affolter VK; Outerbridge CA; Watson JL; Galuppo LD; Buerchler S; Kumar V; Walker NJ; Borjesson DL
    Cytotherapy; 2011 Nov; 13(10):1180-92. PubMed ID: 21899391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic tracking of
    Beerts C; Brondeel C; Pauwelyn G; Depuydt E; Tack L; Duchateau L; Xu Y; Saunders JH; Peremans K; Spaas JH
    Stem Cell Res Ther; 2021 Jul; 12(1):393. PubMed ID: 34256833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Equine metacarpophalangeal joint partial and full thickness defects treated with allogenic equine synovial membrane mesenchymal stem/stromal cell combined with umbilical cord mesenchymal stem/stromal cell conditioned medium.
    Reis IL; Lopes B; Sousa P; Sousa AC; Rêma A; Caseiro AR; Briote I; Rocha AM; Pereira JP; Mendonça CM; Santos JM; Lamas L; Atayde LM; Alvites RD; Maurício AC
    Front Vet Sci; 2024; 11():1403174. PubMed ID: 38840629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.